Características clínicas e histopatológicas de ojos enucleados por melanoma uveal en un hospital terciario en España

Singh, 2011, Uveal melanoma: Trends in incidence, treatment, and survival, Ophthalmology, 118, 1881, 10.1016/j.ophtha.2011.01.040 Raivio, 1977, Uveal melanoma in Finland: An epidemiological, clinical, histological, and prognostic study, Acta Ophthalmol Suppl, 133, 1 Seddon, 1990, Host factors UV radiation, and risk of uveal melanoma: A case-control study, Arch Ophthalmol, 108, 1274, 10.1001/archopht.1990.01070110090031 Gonder, 1982, Uveal malignant melanoma associated with ocular and oculodermal melanocytosis, Ophthalmology, 89, 953, 10.1016/S0161-6420(82)34694-1 Hawkins BS, Schachat AP. Collaborative Ocular Melanoma Study. En: Schachat AP, Sadda SR, Hinton DR, Wilkinson CP, Wiedemann P, editores. Ryan's retina. Cleveland: Elsevier Inc.; 2017. p. 2613-20. Hawkins, 2004, The COMS randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24, Am J Ophthalmol, 138, 936, 10.1016/j.ajo.2004.07.006 2006, The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors. COMS report No. 28, Arch Ophthalmol, 124, 1684, 10.1001/archopht.124.12.1684 1997, Mortality in patients with small choroidal melanoma. COMS report no. 4. The Collaborative Ocular Melanoma Study Group, Arch Ophthalmol, 115, 886, 10.1001/archopht.1997.01100160056009 Kivelä, 2012, Diagnosis of uveal melanoma, Dev Ophthalmol, 49, 1, 10.1159/000330613 Nathan, 2015, Uveal Melanoma UK National Guidelines, Eur J Cancer, 51, 2404, 10.1016/j.ejca.2015.07.013 Lorigan, 1991, The prevalence and location of metastases from ocular melanoma: Imaging study in 110 patients, AJR Am J Roentgenol, 157, 1279, 10.2214/ajr.157.6.1950883 Purohit, 2016, Orbital tumours and tumour-like lesions: Exploring the armamentarium of multiparametric imaging, Insights Imaging, 7, 43, 10.1007/s13244-015-0443-8 Diener-West, 2005, Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26, Arch Ophthalmol, 123, 1639, 10.1001/archopht.123.12.1639 Seddon, 2017, Prognosis of posterior uveal melanoma, 2523 Callender, 1931, Malignant melanotic tumors of the eye: A study of histologic types in 111 cases, Trans Am Acad Ophthalmol Otolaryngol, 3, 131 Seddon, 1987, Death from uveal melanoma: Number of epithelioid cells and inverse SD of nucleolar area as prognostic factors, Arch Ophthalmol, 105, 801, 10.1001/archopht.1987.01060060087039 Pe’er, 2001, Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: An EORTC ocular oncology group study, Br J Ophthalmol., 85, 1208, 10.1136/bjo.85.10.1208 Shields, 2012, Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8033 cases, Retina, 32, 1363, 10.1097/IAE.0b013e31824d09a8 Singh, 2004, Sunlight exposure and pathogenesis of uveal melanoma, Surv Ophthalmol, 49, 419, 10.1016/j.survophthal.2004.04.009 Flocks, 1955, The size and shape of malignant melanomas of the choroid and ciliary body in relation to prognosis and histologic characteristics: A statistical study of 210 tumors, Trans Am Acad Ophthalmol Otolaryngol, 59, 740 Coleman, 1996, Prognostic value of morphometric features and the callender classification in uveal melanomas, Ophthalmology, 103, 1634, 10.1016/S0161-6420(96)30452-1 Rouberol, 2004, Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years’ experience with beta-rays), Am J Ophthalmol, 137, 893, 10.1016/j.ajo.2003.12.032 1998, Histopathologic characteristics of uveal melanomas in eyes enucleated from the Collaborative Ocular Melanoma Study. COMS report no. 6, Am J Ophthalmol, 125, 745, 10.1016/S0002-9394(98)00040-3 Bacin, 1988, Prognostic study of malignant melanoma of the uvea treated by enucleation, J Fr Ophtalmol, 11, 639 Mäkitie, 1999, Microvascular loops and networks as prognostic indicators in choroidal and ciliary body melanomas, J Natl Cancer Inst, 91, 359, 10.1093/jnci/91.4.359 Foss, 1996, Microvessel count predicts survival in uveal melanoma, Cancer Res, 56, 2900 Wolff-Korman, 1992, Duplex and color Doppler ultrasound in the differential diagnosis of choroidal tumors, Acta Ophthalmol Suppl, 204, 66 Guthoff, 1989, Doppler sonographic findings in intraocular tumors, Fortschr Ophthalmol, 86, 239 Toledo, 2017, Use of OCT Angiography in Choroidal Melanocytic Tumors, J Ophthalmol, 2017, 1573154, 10.1155/2017/1573154 Shields, 2002, Plaque radiotherapy for large posterior uveal melanoma (≥8mm thick) in 354 consecutive patients, Ophthalmology, 109, 1838, 10.1016/S0161-6420(02)01181-8 Karlsson, 1989, Recurrence of posterior uveal melanoma after 60Co episcleral plaque therapy, Ophthalmology, 96, 382, 10.1016/S0161-6420(89)32882-X Seddon, 1983, A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma, Arch Ophthalmol, 101, 1894, 10.1001/archopht.1983.01040020896012 Mäkitie, 2001, Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma, Invest Ophthalmol Vis Sci, 42, 1414 Heindl, 2007, High-dose 106Ruthenium plaque brachytherapy for posterior uveal melanoma. A clinico-pathologic study, Ophthalmologe, 104, 149, 10.1007/s00347-006-1451-3 Récsán, 2002, MRI for the evaluation of scleral invasion and extrascleral extension of uveal melanomas, Clin Radiol, 57, 371, 10.1053/crad.2001.0859 Hosten, 1997, Uveal melanoma: Detection of extraocular growth with MR imaging and US, Radiology, 202, 61, 10.1148/radiology.202.1.8988193